BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 6218218)

  • 1. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.
    Rolink AG; Gleichmann E
    J Exp Med; 1983 Aug; 158(2):546-58. PubMed ID: 6224882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST; Radaszkiewicz T; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases.
    Gleichmann E; Gleichmann H
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):115s-120s. PubMed ID: 3159804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference.
    Ito S; Ueno M; Nishi S; Arakawa M; Ikarashi Y; Saitoh T; Fujiwara M
    Autoimmunity; 1992; 12(2):79-87. PubMed ID: 1617113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.
    Rozendaal L; Pals ST; Gleichmann E; Melief CJ
    Clin Exp Immunol; 1990 Dec; 82(3):527-32. PubMed ID: 2148286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal lesions of exocrine glands and insulitis induced by L3T4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity.
    Saitoh T; Fujiwara M; Asakura H
    Clin Immunol Immunopathol; 1990 Dec; 57(3):339-50. PubMed ID: 1978809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lesions induced by graft-versus-host reaction across MHC class II antigens: an implication for animal model of primary biliary cirrhosis.
    Saitoh T; Fujiwara M; Nomoto M; Makino M; Watanabe H; Ishihara K; Kamimura T; Ichida F
    Clin Immunol Immunopathol; 1988 Oct; 49(1):166-72. PubMed ID: 3409553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice.
    Mowat AM; Sprent J
    Transplantation; 1989 May; 47(5):857-63. PubMed ID: 2655224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune and non-immune factors in cryopreserved tissues.
    Tomita Y; Yoshikawa M; Zhang Qi; Uchida T; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    J Heart Lung Transplant; 2003 May; 22(5):560-7. PubMed ID: 12742419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.